Provided by Tiger Trade Technology Pte. Ltd.

Greenfire Resources Ltd

5.80
+0.21003.76%
Post-market: 5.800.00000.00%16:15 EDT
Volume:625.84K
Turnover:3.57M
Market Cap:1.39B
PE:-22.92
High:5.81
Open:5.57
Low:5.43
Close:5.59
52wk High:7.16
52wk Low:4.15
Shares:240.00M
Float Shares:65.27M
Volume Ratio:1.05
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2530
EPS(LYR):0.4786
ROE:-3.63%
ROA:0.48%
PB:1.73
PE(LYR):12.12

Loading ...

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

GlobeNewswire
·
Sep 17

Oil Stocks Retail Investors Are Watching For Direct Crude Price Exposure

Simply Wall St.
·
Aug 31

Canadian Stocks Decline 0.1% in Early Trading

Dow Jones
·
Aug 17

Canadian Stocks Rise 0.7%

Dow Jones
·
Aug 08

Canadian Stocks Flat in Early Trading

Dow Jones
·
Aug 06

Greenfire Resources Q2 EPS $0.31 Down From $0.50 YoY, Sales $129.597M Up From $104.422M YoY

Benzinga Earnings
·
Aug 05

Greenfire Resources Ltd. Expected to Post Earnings of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 05

Thomas Ebbern Bought 255% More Shares In Greenfire Resources

Simply Wall St.
·
Jul 16

RBC Capital Reaffirms Their Hold Rating on Greenfire Resources (GFR)

TIPRANKS
·
Jul 16

Greenfire Resources initiated with a Sector Perform at RBC Capital

TIPRANKS
·
Jul 06

Funds: An Old-School Value Fund With No Tech Is Beating the Market -- Barron's

Dow Jones
·
Jun 20

How This Old-School Value Fund With No Tech Stocks Is Beating the Market -- Barrons.com

Dow Jones
·
Jun 17

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

GlobeNewswire
·
May 22

Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 14

Greenfire Resources Ltd expected to post earnings of 8 cents a share - Earnings Preview

Reuters
·
May 02

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 22

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

GlobeNewswire
·
Apr 07

Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 24